We’re Here to Help
SNMMI's communications staff is available to handle your inquiries, arrange interviews with experts, provide copies of research articles and more.
For assistance, please contact Kimberly Brown, associate director of public relations, at kbrown@snmmi.org or at (703) 652-6773.
Media
SNMMI is dedicated to being the premier source of information on nuclear medicine and molecular imaging. SNMMI's online newsroom provides reporters with the information needed to write articles and gain background information on the many topics related to molecular imaging and therapy and nuclear medicine.
SNMMI issues press releases on new research, society updates and industry news for members of the press. Check back frequently to see what's new with SNMMI.
View press releases on the latest research and news from SNMMI.
Nuclear and molecular imaging are vital elements of today's medical practice, adding an additional dimension to diagnosis that can change the way diseases are understood and treated. Nuclear medicine therapies treat specific diseases, such as lymphoma or thyroid cancer, by allowing a high dose of medicine to be delivered directly to a tumor or problem area. SNMMI's fact sheets explain how nuclear medicine and molecular imaging can help diagnose and/or treat a wide range of diseases.
SNMMI publishes two peer-reviewed medical journals—The Journal of Nuclear Medicine (JNM) and The Journal of Nuclear Medicine Technology (JNMT)—which feature the latest in molecular imaging research. JNM and JNMT are the most widely read peer-reviewed publications in molecular imaging, nuclear medicine and allied disciplines.
Every month, JNM brings readers around the globe clinical investigations, basic science reports, continuing education articles, book reviews, employment opportunities, and updates on rapidly changing issues in practice and research. JNM's Newsline offers in-depth reporting on news affecting every facet of the field—the latest scientific events, government decisions, industry developments, socio-economic trends, and a broad selection of reviews from the literature.
Published quarterly, JNMT focuses on technology, quality assurance, radiation safety, and the clinical applications of nuclear medicine. Each issue features continuing education articles written by leading educators in nuclear medicine technology as well as news and updates on practice, licensure, and credentialing for nuclear medicine technologists. Practitioners from across the imaging sciences turn to JNMT for peer-reviewed information related to daily clinical practice.
SNMMI can connect you with subject-matter experts on a variety of topics who are ready to respond to tight deadlines. Contact Kimberly Brown, SNMMI's associate director of public relations, at kbrown@snmmi.org or at (703) 652-6773, to set up an interview with SNMMI's leadership or with one of its many experts on oncology, brain disease, heart disease, radiopharmaceuticals, reimbursement and more.
SNMMI Leadership
- Gary Dillehay, MD, FACNM, FACR
SNMMI 2013-2014 President - Peter Herscovitch, MD
SNMMI 2013-2014 President-Elect - Hossein Jadvar, MD, PhD, MPH, MBA, FACNM
SNMMI 2013-2014 Vice President-Elect - Frederic H. Fahey, DSc
SNMMI 2012-2013 President
SNMMI-TS Leadership
- Scott Holbrook, BS, CNMT, FSNMMI-TS
SNMMI-TS 2013-2014 President - April Mann, NCT, RT(N), FSNMMI-TS
SNMMI-TS 2013-2014 President-Elect
Join SNMMI on our social media networks to stay updated on the latest from the society and the nuclear medicine and molecular imaging field.
 |
 |
 |
 |
SNMMI 2014 Annual Meeting News, Announcements, Research
June 7-11, St. Louis, Mo.
St. Louis Convention Center
Scientific Research (All releases embargoed until Monday, June 9, 2014, at 12:30 pm EDT)
Cardiovascular
PET/MR Is Superior For Verifying Coronary Arterial Disease
Stem Cell–Stimulating Therapy Saves Heart Attack Patients
General Clinical Specialties
SPECT/CT Reveals Best Treatment for Low Back Pain
Chemo-Radionuclide Therapy Halts Neuroendocrine Cancer
Instrumentation and Data Analysis
Radioluminescence Tells the Story of Single Cells
Opti-SPECT/PET/CT: Five Different Imaging Systems Now Combined
Molecular Targeting Probes
Enzyme-Inhibition Could Revolutionize Molecular Imaging
Molecular Imaging Gets to the Root of Rheumatoid Arthritis
Neurosciences
Depression in the Elderly Linked to Alzheimer’s Risk
REM Sleep Disturbance Signals Future Neurodegenerative Disease
Oncology - Basic
A Few Circulating Cancer Cells Could Cue Risk of Metastases
Molecular Imaging Finds Novel Way to Knock Down Breast Cancer
Oncology - Clinical
PSMA-Based Imaging Traces Even Treatment-Resistant Prostate Cancer
Presurgical SPECT/CT Shows More Cancer Than Current Standard
Technologist
Molecular Breast Imaging Protocol Unmasks More Cancer
SNMMI Image of the Year (Release embargoed until Monday, June 9, 2014, at 12:30 pm EDT)
SNMMI/SNMMI-TS Officers (All releases embargoed until Monday, June 9, 2014, at 11:00 am EDT)
SNMMI Elects Peter Herscovitch, MD, FACP, FRCPC, as President During 2014 Annual Meeting
SNMMI Elects Hossein Jadvar, MD, PhD, MPH, MBA, FACNM, as President-Elect During 2014 Annual Meeting
SNMMI Elects Sally W. Schwarz, MS, RPh, BCNP, as Vice President-Elect During 2014 Annual Meeting
SNMMI Announces April Mann, MBA, CNMT, NCT, RT(N), FSNMMI-TS, as President of Technologist Section during 2014 Annual Meeting
SNMMI Announces Aaron Scott, MIS, CNMT, NMAA, FSNMMI-TS, as President-Elect of Technologist Section During 2014 Annual Meeting
Awards
Barry A. Siegel, MD, Receives 2014 Benedict Cassen Prize for Research in Nuclear Medicine (Embargoed until Monday, June 9, 2014, at 10:00 am EDT)
- July 24, 2014 —
AAPM: Radiomics helps fine-tune radiation therapy dose
By extracting statistical information and other measurements from PET images using a data analysis technique called radiomics, researchers have developed a way to determine radiation therapy dose more accurately, according to a study presented this week at the American Association of Physicists in Medicine (AAPM) meeting in Austin, TX.
(MI: Making a Difference) - July 24, 2014 —
Radiocholine PET/CT has a niche in prostate imaging
Selection of patients with advanced prostate cancer who are eligible for salvage radiation therapy could be improved with the use of radiocholine PET/CT, according to a review of recent research published today in the Journal of Nuclear Medicine .
(MI: Making a Difference) - July 18, 2014 —
AAIC: F-18 Flute shown to change management in 20% of dementia patients
The amyloid PET agent F-18 flutemetamol (Vizamyl) was the topic of two scientific sessions at the Alzheimer’s Association International Conference (AAIC), which concluded yesterday in Copenhagen. Results of one study showed how patients with mild cognitive impairment (MCI) whose scans were positive for flutemetamol were 2.5 times more likely to progress to Alzheimer's disease. Another study of early onset dementia patients showed improvements in clinical decision making and clinician confidence as a result of information gleaned from flutemetamol PET.
(MI: Making a Difference) - July 17, 2014 —
PET agents differentiate Alzheimer's, cardiovascular disease
Researchers have found that using PET brain imaging with florbetapir and FDG can differentiate cardiovascular disease from symptoms of mild cognitive impairment or Alzheimer's disease. The combination can also detect amyloid plaques in patients with cardiovascular disease.
(MI: Making a Difference)
Featured Resources
- Appropriate Use Criteria
- Guidance
Tools, supported by evidence, to harmonize the practice of nuclear medicine using a progressive and safe approach.
- SNMMI Journals
Learn more about journals published by or sponsored by the Society of Nuclear Medicine and Molecular Imaging.
- Position Statements
- Legislative Issues
SNMMI monitors multiple federal legislative issues and provides resources including issue summaries, letters to Congress, and analysis.